Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft

Anat Bar-Shira, Jehonathan H. Pinthus, Uri Rozovsky, Myriam Goldstein, William R. Sellers, Yuval Yaron, Zelig Eshhar, Avi Orr-Urtreger*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

We analyzed a prostate cancer xenograft derived from a locally advanced tumor using combined cytogenetic, array-based comparative genomic hybridization and expression analyses. This analysis revealed that genes in the 20q13 chromosomal region, CSE1L, ZNF217, MYBL2, and STK15, were significantly overexpressed in this tumor. The expression pattern of these genes was then confirmed in two large human prostate cancer microarray databases. Furthermore, the MYBL2 and STK15 have been significantly overexpressed in prostate metastases, allowing a clear distinction between localized tumors and metastases. Our data suggest these genes to be involved in advanced stages of prostate tumorigenesis and as such, they may serve as markers for tumor progression.

Original languageEnglish
Pages (from-to)6803-6807
Number of pages5
JournalCancer Research
Volume62
Issue number23
StatePublished - 1 Dec 2002

Fingerprint

Dive into the research topics of 'Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft'. Together they form a unique fingerprint.

Cite this